Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma
Mark C. de Gooijer(Manchester Academic Health Science Centre), Olaf van Tellingen(Oncode Institute)
Cited by 0
Related Papers
Buparlisib is a brain penetrable pan-PI3K inhibitor
|Scientific Reports|2018|80
ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost
|Cell Reports Medicine|2021|59
Acquired and intrinsic resistance to vemurafenib in <scp> BRAF <sup>V600E</sup> </scp> ‐driven melanoma brain metastases
|FEBS Open Bio|2023|2
Acquired and intrinsic resistance to vemurafenib in BRAF <sup>V600E</sup> -driven melanoma brain metastases
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0